LENZ Therapeutics, Inc. (LENZ)
NASDAQ·Healthcare·Biotechnology
$9.29
-4.82%
Mkt Cap $294.10M
Next Earnings
In 8 daysWed, May 6, 2026
EPS Estimate
-$1.05
6 analysts
Revenue Estimate
$2.19M
Last quarter: missed by -27.47% on EPS, -48.50% on revenue.
EPS — Estimate vs Actual
Mkt Cap
$294.10M
P/E
—
Fwd P/E
—
P/S
15.41
Rev TTM
—
EPS TTM
-$2.81